Effectiveness of Homoeopathic Medicines on Personality Disorder.
Phase 3
- Conditions
- Health Condition 1: F603- Borderline personality disorder
- Registration Number
- CTRI/2022/10/046694
- Lead Sponsor
- Dr Fasila Aliyar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of both genders age between 18 and 60 years of age
Those who have fulfilled ICD 10 diagnostic criteria of Personality disorder
Exclusion Criteria
Patients with organic psychosis.
Cases with life-threatening Systemic illness.
Substance induced psychotic disorder.
Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the usefulness of individualized homoeopathic medicine in reducing <br/ ><br>emotional dysregulations on emotionally unstable Personality disorder by using DERS <br/ ><br>scale.Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method To find out change in quality of life in persons with Personality disorders, after <br/ ><br>individualized Homoeopathic medicine by using WHO QOLTimepoint: 1 year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie homoeopathic treatment effects in borderline personality disorder?
How does individualized homoeopathy compare to standard-of-care therapies for emotionally unstable personality disorder?
Are there specific biomarkers associated with response to homoeopathic interventions in F603 disorders?
What adverse events are reported in phase III homoeopathic trials for personality disorders?
What combination therapies or alternative approaches show promise in managing borderline personality disorder alongside homoeopathy?